Plain-English translation of NCT06921603 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a simple bedside ultrasound scan — similar to what pregnant women receive — can help doctors make better decisions about giving you diuretics (water pills) when you're hospitalized for acute heart failure. By measuring fluid levels in a vein in your neck using ultrasound, doctors may be able to tell when you're ready to leave the hospital and reduce your chances of coming back within 30 days.
Right now, doctors often rely on physical exams and chest X-rays to decide when heart failure patients are ready to go home, but these methods aren't very accurate. Many patients still have too much fluid in their bodies when they're discharged, which leads to them being readmitted to the hospital within a month — and sometimes causes kidney damage. This study wants to see if this new treatment approach using real-time ultrasound imaging can solve that problem.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you'll receive either standard heart failure treatment or standard treatment plus daily ultrasound scans of your neck vein to guide your diuretic doses — with the goal of reducing readmissions. Either way, doctors will perform brief ultrasound imaging each day to measure fluid levels and assess your progress. The study will track whether you are readmitted to the hospital within 30 days and monitor your kidney function.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
United States